Quantcast

Latest Selective androgen receptor modulator Stories

Arctic Ground Squirrels Muscle Up To Hunker Down
2011-09-18 05:20:58

  Animals burn protein during long, cold hibernation When Arctic ground squirrels are getting ready to hibernate they don't just get fat — they pack on muscle at a rate that would make a bodybuilder jealous. And they do it without suffering the harmful effects that high levels of testosterone and other anabolic steroids usually cause. University of Toronto Scarborough (UTSC) researchers have started to untangle how the squirrels manage it, and their results could someday have...

2009-11-19 14:46:56

Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their performance enhancing qualities. The availability of authentic SARMs was recently demonstrated for the first time by the detection of the drug candidate Andarine in a...

2008-10-14 03:00:12

GTx, a biopharmaceutical company, has announced positive topline results of a Phase II clinical trial evaluating Ostarine, an investigational selective androgen receptor modulator, in patients with cancer induced muscle loss, also known as cancer cachexia. In this analysis, the study met its primary endpoint of absolute change in total lean body mass (muscle) compared to placebo and the secondary endpoint of muscle function (performance) after 16 weeks of treatment. GTx plans to present...

2008-10-13 06:00:18

GTx, Inc. (NASDAQ: GTXI) today announced topline results of a Phase II clinical trial evaluating Ostarine(TM) (MK-2866), an investigational selective androgen receptor modulator (SARM), in patients with cancer induced muscle loss, also known as cancer cachexia. In this analysis, the study met its primary endpoint of absolute change in total lean body mass (muscle) compared to placebo and the secondary endpoint of muscle function (performance) after 16 weeks of treatment. GTx and Merck &...

2008-07-31 09:00:28

Currently, approximately 10 million people in the U.S. are estimated to have osteoporosis, and another 34 million are believed to have low bone mass, placing them at risk for developing osteoporosis. Osteoporosis is a natural part of aging; bone mass and density decline is a major health threat for more than 44 million people in the U.S. According to a new osteoporosis drug and device products report produced by Medtech Insight/Windhover Information, this huge and promising market will...


Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.